Jove
Visualize
Contact Us

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Drug Regulation01:25

Drug Regulation

1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

405
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
405
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Explainable Artificial Intelligence in Pharmacovigilance and Drug Safety: A Systematic Review of Enhancing Transparency and Regulatory Acceptance.

Current drug safety·2026
Same author

Evolving Global Regulatory Frameworks for Drug Discovery and Development: Harmonization and Future Directions.

Current drug discovery technologies·2026
Same author

Pharmaceutical Industry 5.0: The Role of Drug Discovery Technology, Innovation, and Digital Transformation in Economic Resilience.

Current drug discovery technologies·2026
Same author

Emerging Innovations in Current Drug Discovery Technologies: The Role of Regulatory Policies and Financial Investments in Healthcare Transformation.

Current drug discovery technologies·2026
Same author

Cybersecurity, Research Data Management (RDM), and Regulatory Compliance in Clinical Trials.

Reviews on recent clinical trials·2025
Same author

Global Analysis of Regulatory Frameworks and Drug Safety Standards in the Drug Approval Process.

Current drug safety·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 28, 2025

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.6K

Pharmacovigilance - Technological Advancements, Recent Developments and Innovations.

Virendra S Gomase1

  • 1S.P. Mandali's Prin. L. N. Welingkar Institute of Management Development & Research, Mumbai, 400019, India.

Current Drug Safety
|February 11, 2025
PubMed
Summary

Pharmacovigilance enhances drug safety by identifying and preventing adverse drug reactions. Technological advancements like AI and EHRs improve medication safety monitoring and patient care.

Keywords:
ADRsPharmacovigilanceartificial intelligence.global and national frameworksmachine learningrecent developmentsregulatory compliancetechnological advancements

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K

Related Experiment Videos

Last Updated: May 28, 2025

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study
09:18

Intraventricular Drug Delivery and Sampling for Pharmacokinetics and Pharmacodynamics Study

Published on: March 31, 2022

2.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

12.8K

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Healthcare Technology

Background:

  • Pharmacovigilance is crucial for preventing adverse drug reactions and ensuring medication benefits outweigh risks.
  • Patient safety and effective drug use are primary objectives of pharmacovigilance.
  • Technological progress has significantly improved drug safety monitoring and management.

Purpose of the Study:

  • To highlight the evolving role of pharmacovigilance in modern healthcare.
  • To emphasize the integration of technology in enhancing adverse drug reaction detection and reporting.
  • To underscore the importance of pharmacovigilance in balancing efficacy, safety, and regulatory compliance.

Main Methods:

  • Review of technological advancements impacting pharmacovigilance.
  • Integration of artificial intelligence (AI) and machine learning (ML) for data analysis and signal detection.
  • Utilization of electronic health records (EHRs) and mobile health (mHealth) for real-time data collection and reporting.

Main Results:

  • Technological advancements have led to more efficient medication safety monitoring.
  • AI/ML applications enhance adverse reaction prediction and signal detection.
  • EHRs and mHealth expedite data collection and adverse drug reaction reporting.

Conclusions:

  • Pharmacovigilance is essential for improving patient safety and ensuring safe drug usage.
  • The integration of advanced technologies like AI, ML, EHRs, and mHealth has significantly improved pharmacovigilance processes.
  • Continuous evolution in pharmacovigilance is vital for maintaining drug efficacy and regulatory compliance.